INTERNATIONAL PATENT: RIGERNA THERAPEUTICS (SUZHOU) CO., LTD., 苏州炫景生物科技有限公司 FILES APPLICATION FOR "DOUBLE-STRANDED OLIGONUCLEOTIDE AND USE THEREOF IN INHIBITING EXPRESSION OF ANGIOTENSINOGEN"

Posted On: 2025-03-08

GENEVA, March 8 -- RIGERNA THERAPEUTICS (SUZHOU) CO., LTD. (Room 702, Building B2, Phase I, Biomedical Industrial Park, No. 218, Xinghu Street, Suzhou Industrial ParkSuzhou, Jiangsu 215128), 苏州炫景生物科技有限公司 (中国江苏省苏州市中国（江苏）自由贸易试验区苏州片区苏州工业园区星湖街218号生物医药产业园一期B1栋9层B908室) filed a patent application (PCT/CN2024/113703) for "DOUBLE-STRANDED OLIGO...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: RIGERNA THERAPEUTICS (SUZHOU) CO., LTD., 苏州炫景生物科技有限公司 FILES APPLICATION FOR "DOUBLE-STRANDED OLIGONUCLEOTIDE AND USE THEREOF IN INHIBITING EXPRESSION OF ANGIOTENSINOGEN"